Literature DB >> 4036118

Primary sclerosing cholangitis--an immunologically mediated disease?

R W Chapman, D P Jewell.   

Abstract

Primary sclerosing cholangitis (PSC) is an uncommon, chronic disorder characterized by inflammatory fibrosis usually involving the entire biliary tree. The etiology has been unknown, but PSC is closely associated with ulcerative colitis, which coexists in more than two thirds of patients with PSC. In recent studies 3% to 5% of all patients with ulcerative colitis had PSC. We propose that PSC is, at least in part, an immunologically mediated disease; it is closely associated with human leckocyte antigens B8 and DR3, and circulating autoantibodies to colon and portal tract are frequently present. The anticolon antibody cross-reacts with enteric Escherichia coli. The disease may possibly be triggered in susceptible patients with ulcerative colitis by immunization with antigens shared between enteric microorganisms and the biliary system.

Entities:  

Mesh:

Year:  1985        PMID: 4036118      PMCID: PMC1306270     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  30 in total

Review 1.  HLA and liver disease.

Authors:  A L Eddleston; R Williams
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

Review 2.  HLA-B27 and the link with rheumatic diseases: recent developments.

Authors:  R W Ebringer
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

3.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

Authors:  R H Wiesner; N F LaRusso
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

4.  Bile acids in liver disease associated with inflammatory bowel disease.

Authors:  J H Siegel; S Barnes; J S Morris
Journal:  Digestion       Date:  1977       Impact factor: 3.216

5.  Hepatotoxic effect of bile acids in inflammatory bowel disease.

Authors:  M J Dew; G P van Berge Henegouwen; A W Huybregts; R N Allan
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

6.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

7.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

8.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

9.  Portal vein bile acids in patients with severe inflammatory bowel disease.

Authors:  R T Holzbach; M E Marsh; M R Freedman; V W Fazio; I Lavery; D A Jagelman
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

10.  Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice.

Authors:  B Bangaru; R Morecki; J H Glaser; L M Gartner; M S Horwitz
Journal:  Lab Invest       Date:  1980-11       Impact factor: 5.662

View more
  5 in total

Review 1.  The immunology of primary sclerosing cholangitis.

Authors:  R W Chapman
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Cytomegalovirus infection and proinflammatory cytokine activation modulate the surface immune determinant expression and immunogenicity of cultured murine extrahepatic bile duct epithelial cells.

Authors:  H Y Hsu; M H Chang; Y H Ni; S F Huang
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

Authors:  R W Chapman; P M Kelly; A Heryet; D P Jewell; K A Fleming
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 4.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.

Authors:  Nieun Seo; So Yeon Kim; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

5.  A Unique Triad: Ulcerative Colitis, Primary Sclerosing Cholangitis, and Autoimmune Hemolytic Anemia.

Authors:  Syeda Naqvi; Syed Askari Hasan; Sameen Khalid; Aamer Abbass; Melanie Albors-Mora
Journal:  Cureus       Date:  2018-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.